Da Vinci Surgical System

The Da Vinci Surgical System is currently one of the most advanced surgical robots in the world, developed by Intuitive Surgical, USA. It achieves high-precision surgical manipulation via minimally invasive techniques and is widely applied across multiple disciplines, including urology, general surgery, gynecology, obstetrics, and cardiothoracic surgery. The following are its primary features and introduction:

System Components

The Da Vinci Surgical System is primarily composed of three parts:

① Surgeon Console: The primary surgeon operates the robotic arms through the console, where the system filters hand tremors to enhance surgical precision.

② Patient-Side Robotic Arm System: Comprising multiple freely rotating robotic arms, equipped with EndoWrist® patented instruments offering seven degrees of freedom, providing greater flexibility than the human hand.

③ Imaging System: Offers a three-dimensional high-definition magnified view (up to 10×), assisting the surgeon in clearly visualizing the operative field.

Core Advantages

① High Precision: Robotic arms can replicate human hand movements while eliminating tremors, suitable for delicate operations (e.g., grape-skin suturing).

② Minimally Invasive Surgery: Accessing the body through small incisions, reducing blood loss, pain, and recovery time.

③ Three-Dimensional High-Definition Visualization: Provides stereoscopic 3D images without the need for special glasses, enhancing surgical visualization.

④ Potential for Remote Operation: With future integration of 5G technology, remote surgery may become feasible.

Clinical Applications

The Da Vinci system has been applied in:

① Urology: Prostatectomy and nephrectomy for prostate and kidney cancers.

② Gynecology: Surgeries for endometrial and cervical cancers.

③ General Surgery: Gastrectomy, intestinal resections, and pancreaticoduodenectomy.

④ Thyroid Surgery: Utilizing axillary or thoraco-mammary approaches to achieve scarless neck procedures.

Development History

① 1999: The first da Vinci robot was introduced; FDA approval followed in 2000.

② 2006: China imported its first da Vinci robot (at Beijing 301 Hospital).

③ 2023: The Chinese version of the "Thoracoabdominal Endoscopic Surgical Control System" was approved, promoting local production.

Future Trends

① Technological Upgrades: Incorporating new functions such as fluorescence imaging and AI assistance.

② Localized Development: China is advancing domestic production to reduce usage costs.

The da Vinci Surgical System represents a transformative innovation in surgical practice; however, its widespread adoption remains constrained by cost and training requirements. With ongoing technological progress, it is poised to play a pivotal role in an expanding range of medical applications.

【IMG1】

【IMG2】